I'm not negative. Just trying to get to the bottom of things. The cash balance is low. Things have taken a long time. Always looked like it could be something but fell short. Think Nigel's team is first class, but even with this team sales have been very slow. The company's 4C isn't being explicit about the FDA and I think they probably should be.
Do you know what the FDA process is. Are they on the clock, how long does the FDA have to respond. How much longer is on the clock. With the meeting due next year I assume the clock is currently stopped.
Have you looked into the cost of goods issue? What assumptions are you making in your model for the cost of goods for sales of $750/-?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-22
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 1249 | 1 |
View Market Depth
| Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |